KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,133,000 | +24.6% | 16,650 | 0.0% | 0.02% | +21.4% |
| Q2 2017 | $1,712,000 | -30.9% | 16,650 | -47.4% | 0.01% | -39.1% |
| Q1 2017 | $2,477,000 | +5.9% | 31,650 | -37.4% | 0.02% | -8.0% |
| Q4 2016 | $2,338,000 | -53.6% | 50,550 | -43.8% | 0.02% | -55.4% |
| Q3 2016 | $5,035,000 | -30.9% | 89,950 | -37.1% | 0.06% | -32.5% |
| Q2 2016 | $7,289,000 | +590.9% | 142,950 | +499.4% | 0.08% | +591.7% |
| Q1 2016 | $1,055,000 | -24.3% | 23,850 | +7.2% | 0.01% | -25.0% |
| Q4 2015 | $1,393,000 | +15.6% | 22,250 | +2.8% | 0.02% | +6.7% |
| Q3 2015 | $1,205,000 | -4.5% | 21,650 | +4.6% | 0.02% | 0.0% |
| Q2 2015 | $1,262,000 | +21.6% | 20,700 | +15.0% | 0.02% | +15.4% |
| Q1 2015 | $1,038,000 | – | 18,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |